Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.

Anticancer research - 1 Jan 2000

Pollard R B, Schmitt D A, Sasaki H, Hayashi Y, Suzuki F

Abstract excerpt

A production of the soluble factor activity in culture fluids of murine splenic mononuclear cells (SMNC) treated with SSM, an immunopotentiator extracted from Mycobacterium tuberculosis strain Aoyama B, was investigated. The soluble factor activity was determined as a mitogenic activity released...

Topics

Adjuvants, Immunologic
Animals
Antigens, Ly
Complement System Proteins
Female
Interleukin-2
Isoantibodies
Lipids
Male
Mannans
Mice
Mice, Inbred BALB C

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Phenotype

Spleen

T-Lymphocytes

Source

Identifiers

PMID: 2346302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-2346302-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.PMID 2346302Read ↗

Immunosuppression by an immunogenic immunomodulating mycobacterial fraction is correlated to changes in phenotype distribution of murine lymphoid cells.Semantic proximity Read ↗

Suppressive activity of splenic macrophages induced by transparent and opaque colonial variants of Mycobacterium avium complex against lymphoproliferative response.Semantic proximity Read ↗

Modulation of immunological responsiveness by pretreatment with a methanol-insoluble fraction of killed tubercle bacilli.Semantic proximity Read ↗

T-cell proliferative response to antigens secreted by Mycobacterium tuberculosisSemantic proximity Read ↗

Beyond the Clinic: The Activation of Diverse Cellular and Humoral Factors Shapes the Immunological Status of Patients with Active TuberculosisSemantic proximity Read ↗

Synovial cells responding to a 65-kDa mycobacterial heat shock protein have a high proportion of a TcR gamma delta subtype uncommon in peripheral blood.Semantic proximity Read ↗

<i>Mycobacterium tuberculosis</i> evades host immunity by recruiting mesenchymal stem cellsSemantic proximity Read ↗

Immunotherapeutics for Tuberculosis in Experimental Animals: Is There a Common Pathway Activated by Effective Protocols?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.